Fei Cao
Zhejiang Key Laboratory Of Imaging And Interventional Medicine
Hangzhou, 310022, China
Hangzhou, 310022, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Monitoring miR-29a for targeted therapy of cholangiocarcinoma based on a photoelectric sensor.
Journal: Mikrochimica acta
Published: May 02, 2025
Hepatic arterial infusion chemotherapy combined with lenvatinib and programmed death receptor-1 inhibitors for hepatocellular carcinoma with Vp4 portal vein tumor thrombus: a multicenter, propensity score matching comparative study.
Journal: Hepatology international
Published: April 27, 2025
Heat Shock Protein 90 Interactome-Mediated Proteolysis Targeting Chimera (HIM-PROTAC) Degrading Glutathione Peroxidase 4 to Trigger Ferroptosis.
Journal: Journal of medicinal chemistry
Published: September 04, 2024
Combined image-guided radiofrequency and iodine-125 seeds implantation in the treatment of recurrent hepatocellular carcinoma after hepatectomy.
Journal: BMC cancer
Published: March 28, 2024
Synthesis and evaluation of WK-X-34 derivatives as P-glycoprotein (P-gp/ABCB1) inhibitors for reversing multidrug resistance.
Journal: RSC medicinal chemistry
Published: November 03, 2023
Research progress on antitumor mechanisms and molecular targets of Inula sesquiterpene lactones.
Journal: Chinese medicine
Published: September 23, 2023
MiR-339-5p Inhibits Ferroptosis by Promoting Autophagic Degradation of FTH1 Through Targeting ATG7 in Liver Cancer Cells.
Journal: Clinical Medicine Insights. Oncology
Published: July 06, 2023
Improved clinical outcomes in advanced hepatocellular carcinoma treated with transarterial chemoembolization plus atezolizumab and bevacizumab: a bicentric retrospective study.
Journal: BMC cancer
Published: April 17, 2023
Design and synthesis of proteolysis-targeting chimeras (PROTACs) as degraders of glutathione peroxidase 4.
Journal: Bioorganic & medicinal chemistry
Published: March 07, 2023
S3I-201 derivative incorporating naphthoquinone unit as effective STAT3 inhibitors: Design, synthesis and anti-gastric cancer evaluation.
Journal: Bioorganic & medicinal chemistry
Published: June 08, 2022
Design, synthesis, and biological characterization of a potent STAT3 degrader for the treatment of gastric cancer.
Journal: Frontiers in pharmacology
Published: May 15, 2022
Efficacy and safety of atezolizumab plus bevacizumab combined with hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma.
Journal: Frontiers in immunology
Published: April 26, 2022
Last Updated: 09/26/2026